Inventor
MASAT LINDA
US21 patents
⚠️ This page may combine multiple inventors who share the name “MASAT LINDA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XOMA TECHNOLOGY LTD
11 patentsUS7829093B2Nov 9, 2010
Method of treating an IL-1 related autoimmune disease or condition
XOMA TECHNOLOGY LTD21 citations96
US7744865B2Jun 29, 2010
IL1-β Binding antibodies and fragments thereof
XOMA TECHNOLOGY LTD23 citations96
US7695717B2Apr 13, 2010
Method of treating an IL-1 related inflammatory disease or condition
XOMA TECHNOLOGY LTD21 citations96
US7582742B2Sep 1, 2009
Method of treating or preventing an IL-1 related disease or condition
XOMA TECHNOLOGY LTD23 citations96
US7531166B2May 12, 2009
IL-1β binding antibodies and fragments thereof
XOMA TECHNOLOGY LTD49 citations96
US7988968B2Aug 2, 2011
Method of treating an IL-1 related coronary condition
XOMA TECHNOLOGY LTD7 citations92
US7943121B2May 17, 2011
IL-1β binding antibodies and fragments thereof
XOMA TECHNOLOGY LTD11 citations92
US7829094B2Nov 9, 2010
Method of treating an IL-1 related cancer
XOMA TECHNOLOGY LTD13 citations92
US7744866B2Jun 29, 2010
IL-1β binding antibodies and binding fragments thereof
XOMA TECHNOLOGY LTD12 citations92
US9206252B2Dec 8, 2015
Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereof
XOMA TECHNOLOGY LTD5 citations84
US8377442B2Feb 19, 2013
Method of treating inflammatory eye disease with IL-1β binding antibodies
XOMA TECHNOLOGY LTD6 citations84
NOVARTIS AG
5 patentsUS7867493B2Jan 11, 2011
PRLR-specific antibody and uses thereof
NOVARTIS AG61 citations95
US8377439B2Feb 19, 2013
Antagonist antibodies against EPHB3
NOVARTIS AG5 citations81
US9541004B2Jan 10, 2017
Antagonist antibodies against EphB3
NOVARTIS AG0 citations51
US8961969B2Feb 24, 2015
Antagonist antibodies against EphB3
NOVARTIS AG0 citations51
US9006398B2Apr 14, 2015
EPHB3-specific antibody and uses thereof
NOVARTIS AG0 citations46